A clinical‑stage biopharmaceutical company focused on developing oral small‑molecule therapies for autoimmune and inflammatory diseases. Its pipeline targets validated immunology pathways, including TYK2 and other mechanisms aimed at conditions such as psoriasis and inflammatory bowel disease. Inves...
3 members of Congress have disclosed 6 trades in Ventyx Biosciences Inc (VNTX), a Healthcare company. The buy/sell breakdown shows 2 purchases versus 4 sales, indicating net selling pressure from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2017-03-31 | MICHAEL T. MCCAUL | sell | $1K – $15K |
| 2017-03-30 | MICHAEL T. MCCAUL | sell | $1K – $15K |
| 2017-03-22 | MICHAEL T. MCCAUL | sell | $1K – $15K |
| 2016-10-05 | MICHAEL T. MCCAUL | buy | $1K – $15K |
| 2016-04-04 | FRED UPTON | sell | $1K – $15K |
| 2008-02-10 | SHELLEY BERKLEY | buy | -392.00 |